naltrexone has been researched along with Amphetamine-Related Disorders in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (25.00) | 29.6817 |
| 2010's | 15 (62.50) | 24.3611 |
| 2020's | 3 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Courtney, KE; Green, R; Grodin, EN; Lim, AC; London, ED; Meredith, LR; Moallem, NR; Ray, LA; Sayegh, P; Venegas, A | 1 |
| Dong, GM; Guo, LK; Han, X; Li, J; Ma, CM; Song, R; Wang, ZY; Wu, N | 1 |
| Bart, G; Carmody, T; Coffin, P; Dela Cruz, A; Ghitza, UE; Kim, M; Ling, W; Nunes, EV; Rush, AJ; Schmitz, J; Sharma, G; Shoptaw, S; Shores-Wilson, K; Sonne, SC; Sparenborg, S; Trivedi, MH; Wahle, A; Wakhlu, S; Walker, R; Wiest, K | 1 |
| Batki, SL; Coffin, PO; Colfax, G; Hern, J; Matheson, T; Santos, D; Santos, GM; Vittinghoff, E | 1 |
| Berrebi, J; Franck, J; Fransson, P; Guterstam, J; Ingvar, M; Jayaram-Lindström, N; Petrovic, P | 1 |
| Cameron, J; Harney, A; Jenner, L; Lee, NK | 1 |
| Dennis, LE; Hoffman, WF; Kohno, M; Korthuis, PT; McCready, H; Schwartz, DL | 1 |
| Anand, S; Chan, EW; Lam, L; Li, X; Tse, ML; Zhao, JX | 1 |
| Ayers, C; Chan, B; Freeman, M; Kansagara, D; Kondo, K; Montgomery, J; Paynter, R | 1 |
| Brensilver, M; Heinzerling, KG; Shoptaw, S | 1 |
| Eastwood, EC; Phillips, TJ | 1 |
| Bujarski, S; Courtney, KE; Heinzerling, K; Leventhal, AM; London, ED; Lunny, K; Miotto, K; Moallem, NR; Ray, LA; Roche, D; Shoptaw, S | 1 |
| Glaser, PE; Hays, LR; Lile, JA; Marks, KR; Rush, CR; Stoops, WW | 1 |
| Beck, O; Franck, J; Hammarberg, A; Jayaram-Lindström, N | 1 |
| Franck, J; Häggkvist, J; Lindholm, S | 1 |
| Belkaï, E; Marie-Claire, C; Noble, F; Scherrmann, JM | 1 |
| Björkholm, C; Franck, J; Häggkvist, J; Lindholm, S; Schilström, B; Steensland, P | 1 |
| Grant, JE; Kim, SW; Odlaug, BL | 1 |
| Daniels, WM; Dimatelis, JJ; Russell, VA; Stein, DJ | 1 |
| Blokhina, E; Föhr, J; Kiviniemi, V; Krupitsky, E; Kuoppasalmi, K; Mamontova, O; Tiihonen, J; Tuomola, P; Verbitskaya, E; Zwartau, E | 1 |
| Carlstein, S; Hulse, G; Kelty, E; Sinclair, R; Thomson, K | 1 |
| Chiu, CT; Ho, IK; Ma, T | 1 |
| Beck, O; Franck, J; Jayaram-Lindström, N; Wennberg, P | 1 |
| Beck, O; Eksborg, S; Franck, J; Hammarberg, A; Jayaram-Lindström, N; Konstenius, M | 1 |
4 review(s) available for naltrexone and Amphetamine-Related Disorders
| Article | Year |
|---|---|
Pharmacotherapy for amphetamine dependence: A systematic review.
Topics: Amphetamine; Amphetamine-Related Disorders; Dextroamphetamine; Humans; Medication Adherence; Methylphenidate; Modafinil; Naltrexone; Randomized Controlled Trials as Topic | 2018 |
Efficacy and safety of naltrexone for amfetamine and methamfetamine use disorder: a systematic review of randomized controlled trials.
Topics: Amphetamine; Amphetamine-Related Disorders; Humans; Methamphetamine; Naltrexone; Narcotic Antagonists; Randomized Controlled Trials as Topic; Treatment Outcome | 2019 |
Pharmacotherapy for methamphetamine/amphetamine use disorder-a systematic review and meta-analysis.
Topics: Amphetamine-Related Disorders; Anticonvulsants; Antidepressive Agents; Antipyretics; Drug Therapy; Humans; Methylphenidate; Naltrexone; Outcome Assessment, Health Care; Varenicline | 2019 |
Pharmacotherapy of amphetamine-type stimulant dependence: an update.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Bupropion; Central Nervous System Stimulants; Humans; Methylphenidate; Naltrexone; Randomized Controlled Trials as Topic | 2013 |
10 trial(s) available for naltrexone and Amphetamine-Related Disorders
| Article | Year |
|---|---|
Bupropion and Naltrexone in Methamphetamine Use Disorder.
Topics: Administration, Oral; Adolescent; Adult; Aged; Amphetamine-Related Disorders; Bupropion; Delayed-Action Preparations; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Injections; Male; Medication Adherence; Methamphetamine; Middle Aged; Naltrexone; Narcotic Antagonists; Young Adult | 2021 |
Extended-release naltrexone for methamphetamine dependence among men who have sex with men: a randomized placebo-controlled trial.
Topics: Adult; Amphetamine-Related Disorders; Delayed-Action Preparations; Double-Blind Method; Homosexuality, Male; Humans; Male; Methamphetamine; Naltrexone; Narcotic Antagonists; San Francisco; Treatment Outcome | 2018 |
Cue reactivity and opioid blockade in amphetamine dependence: A randomized, controlled fMRI study.
Topics: Adult; Amphetamine-Related Disorders; Attention; Conditioning, Psychological; Corpus Striatum; Craving; Cues; Female; Gyrus Cinguli; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Occipital Lobe; Prefrontal Cortex; Time Factors | 2018 |
A preliminary randomized clinical trial of naltrexone reduces striatal resting state functional connectivity in people with methamphetamine use disorder.
Topics: Adult; Amphetamine-Related Disorders; Amygdala; Delayed-Action Preparations; Female; Hippocampus; Humans; Magnetic Resonance Imaging; Male; Methamphetamine; Middle Aged; Naltrexone; Narcotic Antagonists; Neural Pathways; Rest; Ventral Striatum | 2018 |
The Effects of Naltrexone on Subjective Response to Methamphetamine in a Clinical Sample: a Double-Blind, Placebo-Controlled Laboratory Study.
Topics: Adult; Amphetamine-Related Disorders; Analysis of Variance; Blood Pressure; Cross-Over Studies; Cues; Double-Blind Method; Female; Heart Rate; Humans; Male; Methamphetamine; Middle Aged; Naltrexone; Narcotic Antagonists; Sex Characteristics; Surveys and Questionnaires; Time Factors; Young Adult | 2015 |
Naltrexone for the treatment of amphetamine dependence: a randomized, placebo-controlled trial.
Topics: Adult; Amphetamine; Amphetamine-Related Disorders; Double-Blind Method; Female; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Secondary Prevention; Substance Abuse Detection; Substance Withdrawal Syndrome; Survival Analysis; Treatment Outcome | 2008 |
A double-blind, placebo-controlled study of N-acetyl cysteine plus naltrexone for methamphetamine dependence.
Topics: Acetylcysteine; Adult; Amphetamine-Related Disorders; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Methamphetamine; Middle Aged; Naltrexone; Young Adult | 2010 |
Naltrexone implant for the treatment of polydrug dependence: a randomized controlled trial.
Topics: Adult; Amphetamine-Related Disorders; Double-Blind Method; Drug Implants; Female; Heroin Dependence; Humans; Male; Naltrexone; Narcotic Antagonists; Substance-Related Disorders; Treatment Outcome; Unsafe Sex | 2012 |
An open clinical trial of naltrexone for amphetamine dependence: compliance and tolerability.
Topics: Adolescent; Adult; Aged; Amphetamine-Related Disorders; Female; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Patient Compliance; Secondary Prevention | 2005 |
Naltrexone attenuates the subjective effects of amphetamine in patients with amphetamine dependence.
Topics: Adult; Aging; Amphetamine-Related Disorders; Central Nervous System Stimulants; Cross-Over Studies; Dextroamphetamine; Double-Blind Method; Endorphins; Half-Life; Humans; Hydrocortisone; Male; Naltrexone; Narcotic Antagonists; Psychiatric Status Rating Scales; Psychological Tests; Substance Withdrawal Syndrome | 2008 |
10 other study(ies) available for naltrexone and Amphetamine-Related Disorders
| Article | Year |
|---|---|
Executive function moderates naltrexone effects on methamphetamine-induced craving and subjective responses.
Topics: Adult; Amphetamine-Related Disorders; Central Nervous System Stimulants; Cognition; Craving; Cross-Over Studies; Double-Blind Method; Executive Function; Female; Humans; Los Angeles; Male; Methamphetamine; Naltrexone; Narcotic Antagonists; Young Adult | 2020 |
Naltrexone attenuates methamphetamine-induced behavioral sensitization and conditioned place preference in mice.
Topics: Amphetamine-Related Disorders; Animals; Behavior, Animal; Central Nervous System Sensitization; Central Nervous System Stimulants; Conditioning, Classical; Disease Models, Animal; Extinction, Psychological; Male; Mental Recall; Methamphetamine; Mice; Motivation; Naltrexone; Narcotic Antagonists | 2021 |
Morphine intake and the effects of naltrexone and buprenorphine on the acquisition of methamphetamine intake.
Topics: Amphetamine-Related Disorders; Animals; Buprenorphine; Choice Behavior; Female; Inbreeding; Male; Methamphetamine; Mice; Morphine; Naltrexone; Narcotic Antagonists; Selection, Genetic | 2014 |
Separate and Combined Effects of Naltrexone and Extended-Release Alprazolam on the Reinforcing, Subject-Rated, and Cardiovascular Effects of Methamphetamine.
Topics: Administration, Intranasal; Adult; Alprazolam; Amphetamine-Related Disorders; Blood Pressure; Cross-Over Studies; Delayed-Action Preparations; Double-Blind Method; Drug Therapy, Combination; Female; GABA Modulators; Heart Rate; Humans; Male; Methamphetamine; Middle Aged; Naltrexone; Narcotic Antagonists; Psychomotor Performance; Reinforcement, Psychology; Self Administration | 2016 |
The effect of naltrexone on amphetamine-induced conditioned place preference and locomotor behaviour in the rat.
Topics: Amphetamine-Related Disorders; Animals; Brain; Central Nervous System Stimulants; Choice Behavior; Conditioning, Classical; Dextroamphetamine; Dose-Response Relationship, Drug; Extinction, Psychological; Male; Motor Activity; Naltrexone; Narcotic Antagonists; Rats; Rats, Wistar; Receptors, Opioid; Social Environment | 2009 |
Modulation of MDMA-induced behavioral and transcriptional effects by the delta opioid antagonist naltrindole in mice.
Topics: Amphetamine-Related Disorders; Animals; Behavior, Animal; Brain; Choice Behavior; Conditioning, Classical; Enkephalins; Gene Expression; Hallucinogens; Mice; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Naltrexone; Narcotic Antagonists; Pro-Opiomelanocortin; Protein Precursors; Receptors, Opioid, delta; RNA, Messenger; Social Environment; Transcription, Genetic | 2009 |
Naltrexone attenuates amphetamine-induced locomotor sensitization in the rat.
Topics: Amphetamine-Related Disorders; Animals; Association Learning; Brain; Central Nervous System Stimulants; Conditioning, Classical; Cues; Dextroamphetamine; Male; Motor Activity; Naltrexone; Narcotic Antagonists; Premedication; Rats; Receptors, Opioid; Substance Withdrawal Syndrome | 2011 |
The effects of lobeline and naltrexone on methamphetamine-induced place preference and striatal dopamine and serotonin levels in adolescent rats with a history of maternal separation.
Topics: Age Factors; Amphetamine-Related Disorders; Animals; Animals, Newborn; Corpus Striatum; Female; Lobeline; Male; Maternal Deprivation; Naltrexone; Narcotic Antagonists; Nicotinic Agonists; Rats; Rats, Sprague-Dawley; Stress, Psychological; Vesicular Monoamine Transport Proteins | 2012 |
A retrospective assessment of the use of naltrexone implants for the treatment of problematic amphetamine use.
Topics: Adult; Amphetamine-Related Disorders; Drug Implants; Female; Humans; Male; Naltrexone; Narcotic Antagonists; Retrospective Studies; Self Report | 2013 |
Attenuation of methamphetamine-induced behavioral sensitization in mice by systemic administration of naltrexone.
Topics: Amphetamine-Related Disorders; Animals; Behavior, Animal; Brain; Central Nervous System Stimulants; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Male; Methamphetamine; Mice; Naltrexone; Narcotic Antagonists | 2005 |